arrow
C

Carlos del Río

myokardia inc. and bristol myers squibb
H指数:23
被引数:1,990

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep-learning analysis of 3D microarchitectural remodeling in hypertrophic cardiomyopathy

肥厚型心肌病中3D微结构重塑的深度学习分析

Science
IF45.8
2026-01-150
PRE
Danicamtiv, a selective agonist of cardiac myosin, for dilated cardiomyopathy: A Phase 2 open-label trial

Danicamtiv,一种心脏肌球蛋白选择性激动剂,用于扩张型心肌病:一项II期开放标签试验

JACC
IF0
2025-09-290
OAAI
FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis
2025-01-270
OAAI
Chronic administration of EDG-7500, a novel sarcomere modulator, prevents increases in cardiac mass, T1 relaxation time, and left ventricular end diastolic pressure in a Yucatan mini-pig model of genetic nonobstructive hypertrophic cardiomyopathy

EDG-7500是一种新型肌球蛋白调节剂,其长期给药可预防遗传性非梗阻性肥厚型心肌病Yucatan小型猪模型中心脏质量、T1弛豫时间和左心室舒张末期压力的升高。

2024-11-120
PRE
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
2024-10-040
OA
Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial
2020-07-1061
OAAI
Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202
2019-04-0113
OAAI